Crupi F, Ciolli G, Piccini M, Scappini B, Fasano L, Quinti E, Pasquini A, Caroprese J, Gianfaldoni G, Motta G, Santi R, Maccari C, Guglielmelli P, Vannucchi AM, Mannelli F. Venetoclax and gilteritinib combination for FLT3-mutated relapsed/refractory acute myeloid leukemia: a real-world single-center experience. haematol [Internet]. 2020Sep.10 [cited 2026Jun.26];. Available from: https://haematologica.org/article/view/14167